High Prevalence of Macrolide-resistance and Molecular Characterization of Streptococcus pyogenes Isolates Circulating

Binghuai Lu1, Yujie Fang2,3, Yanyan Fan4

  • 1Department of Laboratory Medicine, Civil Aviation General Hospital, Peking University Civil Aviation School of Clinical MedicineBeijing, China.

Insights

This study analyzed 140 Streptococcus pyogenes clinical isolates in China, revealing high genetic diversity and significant macrolide resistance. Surveillance of these characteristics is crucial for public health prevention and treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Streptococcus pyogenes (group A Streptococcus) causes diverse infections, from mild to severe.
  • Understanding its epidemiology is vital for national prevention and treatment practices.
  • Data on circulating strains in China is essential for targeted interventions.

Purpose of the Study:

  • To characterize the emm types, virulence factors, and antibiotic resistance of S. pyogenes clinical isolates in China.
  • To assess the genotypic diversity and prevalence of resistance among these isolates.
  • To provide data for national surveillance and inform clinical practice.

Main Methods:

  • Collected 140 S. pyogenes isolates (38 invasive, 102 noninvasive) from 10 hospitals in China (2009-2016).
  • Utilized classical and molecular techniques for emm typing, virulence gene detection, and antibiotic resistance profiling.
  • Performed multilocus sequence typing (MLST) to determine sequence types (STs).

Main Results:

  • Identified 15 emm types and 31 subtypes, with emm12, emm1, and emm89 dominating. Identified 8 new emm variant subtypes.
  • All strains harbored speB and slo; high prevalence of smeZ, speF, and speC was observed.
  • Detected 22 STs, including 4 new ones. High resistance rates to erythromycin (93.5%), clindamycin (94.2%), and tetracycline (86.4%) were found, while susceptibility to penicillin and vancomycin remained high.

Conclusions:

  • S. pyogenes in China exhibits significant genotypic diversity.
  • High prevalence of macrolide and tetracycline resistance is a major concern.
  • Continuous surveillance and updated treatment guidelines are necessary to combat S. pyogenes infections.